Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
Bitte melden Sie sich an um selbst Rezensionen oder Kommentare zu erstellen.
Zitieren Sie diese Publikation
Mehr Zitationsstile
- bitte auswählen -
%0 Journal Article
%1 raoult2020hydroxychloroquine
%A Raoult, Didier
%A Million, Matthieu
%A Gautret, Philippe
%A Lagier, Jean-Christoph
%A Colson, Philippe
%A Parola, Philippe
%A Rolain, Jean-Marc
%D 2020
%K (h)cq azm covid-19 raoult
%T Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
@article{raoult2020hydroxychloroquine,
added-at = {2020-07-12T17:22:12.000+0200},
author = {Raoult, Didier and Million, Matthieu and Gautret, Philippe and Lagier, Jean-Christoph and Colson, Philippe and Parola, Philippe and Rolain, Jean-Marc},
biburl = {https://www.bibsonomy.org/bibtex/2f51505356d4aee28706ea168a9c49039/fordham1},
description = {Response-to-Mr.-David-Spencer-ELSEVIER.pdf},
interhash = {56944883f42af6c3b1de986d01f87c67},
intrahash = {f51505356d4aee28706ea168a9c49039},
keywords = {(h)cq azm covid-19 raoult},
timestamp = {2020-07-12T17:22:12.000+0200},
title = {Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier)
},
year = 2020
}
